Bromhexine, lidocaine, oxytetracycline (Bisolvomycin Vet)

Listings for this ingredient that could not be applied to this product

• S4: Lidocaine

  • when intended for ophthalmic or parenteral use;
  • when intended for the treatment of neuropathic pain associated with previous herpes zoster infection;
  • except when intended for topical use; (S1)
  • except in oral preparations containing 2 percent or less of lidocaine per dosage form. (S1)

  Consolidated Schedules 06 July 2026, lines 6923 to 6935

• S4: Oxytetracycline

  • except when listed elsewhere in the Schedules and except preparations thereof for the treatment of animals and registered in terms of the provisions of the Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act, 1947 (Act 36 of 1947).

  Consolidated Schedules 06 July 2026, lines 7449 to 7451

• S2: Bromhexine

  Consolidated Schedules 06 July 2026, line 1684

• S1: Lidocaine

  • when intended for topical use;
  • in oral preparations containing 2 percent or less of lidocaine, per dosage unit;
  • except when intended for ophthalmic or parenteral use; (S4)
  • except when intended for the treatment of neuropathic pain associated with previous herpes zoster infection. (S4)

  Consolidated Schedules 06 July 2026, lines 777 to 786

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.